Gosebruch Henry O has filed 3 insider transactions across 1 company since September 2023.
Most recent transaction: a grant/award of 80000 shares of Neumora Therapeutics, Inc. ($NMRA) on February 14, 2024.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | Gosebruch Henry O | President & CEO | A | Common Stock | 80000 | $0.00 | 604,793.0000 | 0 | 15.24% | 0.00% |
| Feb. 14, 2024 | Neumora Therapeutics, Inc. | $NMRA | Gosebruch Henry O | President & CEO | A | Stock Option (Right to Buy) | 160000 | $0.00 | 160,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 19, 2023 | Neumora Therapeutics, Inc. | $NMRA | Gosebruch Henry O | President & CEO | P | Common Stock | 15000 | $12.62 | 524,793.0000 | 0 | 2.94% | 0.00% |